PANEL - Will AI Help to Enhance & Personalise Healthcare?

Panelists:

Cosima Gretton, Guy's and St Thomas' NHS Foundation Trust
Cosima is a doctor, health tech consultant and entrepreneur. She has a background in psychology and a special interest in the challenges of designing technology for use in expert domains. She is currently working with Outcomes Based Healthcare on a project funded by Innovate UK using machine learning and smartphone sensor data to passively monitor health outcomes in diabetics. She is an alumnus of the Singularity University Graduate Studies Programme and currently an Academic Foundation trainee in Psychiatry and Psychological Medicine at St Thomas’s Hospital. She is the founder of AXNS Collective, a science communication company funded by the Wellcome Trust and the Arts Council curative collaborations between artists and scientists.

Reza Khorshidi, The George Institute for Global Health
Reza Khorshidi is the Head of Science, EMEA and Special Projects Lab at AIG; he built teams of elites that delivered a wide of range of data-driven products, apps, solutions and consulting to AIG's global business (incl. P&C, Life and Health). He also is a fellow at Oxford Martin School, where he leads the program on Machine Learning and Biomedical Informatics. He obtained his DPhil in computational neuroscience and machine learning, from the University of Oxford in 2010, and joined Opera Solutions as an Analytics Lead (leading engagements in healthcare, government, finance, social media and telco). His main areas of interest include, Biomedical Informatics, Machine Learning (incl. Bayesian Learning and Deep Learning), Financial Services, Insurance, Financial Services and Insurance, Population Health, and Innovative Mechanisms of Delivery of Care.

Mahiben Maruthappu, NHS England
Mahiben is a practicing doctor and Senior Fellow to the CEO of NHS England, advising on £100 billion of annual health spending, with a focus on innovation and technology. He co-founded the NHS Innovation Accelerator and the NHS Diabetes Prevention Programme. Mahiben has advised a range of organisations, from start-ups to multilaterals, including the Swiss government and the WHO. He has a strong interest in research with over 80 peer-reviewed publications and 50 academic awards. Mahiben was educated at Oxford, Cambridge and Harvard universities; he was the first person from British healthcare to be included in Forbes’ 30 under 30.

Nathan Benaich, Playfair Capital
I joined Playfair Capital in 2013 to focus on deal sourcing, due diligence, and helping our companies grow. I'm particularly interested in artificial intelligence and machine learning, infrastructure-as-a-service, mobile, and bioinformatics. I've led, originated or participated in Seed through Growth investments including Mapillary, Appear Here, Dojo, and Festicket. Prior to Playfair, I earned an M.Phil and Ph.D in oncology as a Gates and Dr. Herchel Smith Scholar at the University of Cambridge, and a BA in biology from Williams College. I've published research focused on technologies to halt the fatal spread of cancer around the body.